| Literature DB >> 8281094 |
Abstract
The American Cancer Society advocates mammography screening for all women from age 40, whereas in Europe it is not recommended for women below the age of 50. Randomised prospective studies have failed to show a significant benefit from screening women aged under 50 and five potentially harmful effects of screening should be considered: lead time, overdiagnosis, radiation exposure, false positive results, and cost. Younger women must be properly informed about the potential for harm as well as for benefit before screening.Entities:
Mesh:
Year: 1993 PMID: 8281094 PMCID: PMC1679470 DOI: 10.1136/bmj.307.6917.1481
Source DB: PubMed Journal: BMJ ISSN: 0959-8138